See our 10 most-read stories related to Japan’s nutrition industry this year, including Shinya Koso’s insights on the enzyme supplement market, Brand’s Suntory D2C new product launches, Mitsubishi’s nicotinamide mononucleotide (NMN) clinical trial and...
A 12-week RCT funded by Mitsubishi Corporation Life Sciences has shown that nicotinamide mononucleotide (NMN) intake has significantly improved certain aspects of muscle mobility, especially gait speed and left grip strength – which the company says presents...
Nicotinamide mononucleotide (NMN) intake improves lower limb function and reduces drowsiness in adults agreed 65 and above, according to an RCT funded by Mitsubishi Corporation Life Sciences Ltd.
Tavelmout Biofarm (TVMB), the first company to open a factory for spirulina production in Brunei, is eyeing commercial success in Japan, with frozen raw spirulina soon to be launched in spring.